None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children aged 6 - 59 months with Severe Acute Malnutrition based on following criteria: a) Weight for length/height z-score (WHZ) b) No Bilateral pitting oedema and no medical complication 2. Children whose families were likely to remain in the study area over the next 4-5 months, and residing in the same at least for the past six months. 3. Children with Severe Acute Malnutrition passing appetite test. 4. Children with above criteria and parent gives informed consent to participate.
Exclusion criteria
Exclusion criteria: 1. Children with Severe Acute Malnutrition and having any acute medical complications (they will be referred to facility based care for initial management / stabilization). 2. Bilateral pitting oedema of any grade. 3. Children where parent rejects to participate. 4. Children with severe illness requiring hospitalisation, haemoglobin 5. Children with congenital anomalies, cerebral palsy, neurogenerative disorders. 6. Children’s who do not have living parents. 7. Children with Co-morbid illness or systemic diseases, malabsorption, irritable bowel syndrome or celiac diseases, chronic diarrhea and chronic infections (HIV, Tuberculosis). 8. Children who have undergone any major surgery in last 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Weight gain: change in g/kg/day between baseline and recovery or 16 weeks of intervention, whichever will be earlier. We will also document the change in weight standard deviation scores from baseline and at different time points of follow up. 2. Recovery/ Discharged/ Cured: WHZ = -2 SD of the WHO standards and absence of oedema of feet at the end of 16-week follow-up 3. Relapse: children hospitalized or develop medical complication at any stage that requires admission (transferred out) and lost to follow-up over 16 weeks of intervention 4. Non responder: Cases who do not meet discharge criteria after 16 weeksTimepoint: 16 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Mortality rate 2. Height gain 3. Hemoglobin status 4. Adverse outcomes of other illness: occurrence of diarrhoea/ fever, RTI etc measured at any time during the 16 weeks of intervention 5. Acceptability of RUTF/ B+ 6. Adherence to treatment Timepoint: 16 week | — |
Countries
India
Contacts
All India Institute of Medical Sciences, AIIMS, New Delhi